Das Supratik, Cano Jennifer, Kalpana Ganjam V
Department of Molecular Genetics, Albert Einstein College of Medicine, New York, New York 10461, USA.
J Biol Chem. 2009 Jul 24;284(30):19903-14. doi: 10.1074/jbc.M808141200. Epub 2009 Apr 27.
INI1/hSNF5/BAF47/SMARCB1 is an HIV-1 integrase (IN)-binding protein that modulates viral replication in multiple ways. A minimal IN-binding domain of INI1, S6 (amino acids 183-294), transdominantly inhibits late events, and down-modulation of INI1 stimulates early events of HIV-1 replication. INI1 both stimulates and inhibits in vitro integration depending on IN concentration. To gain further insight into its role in HIV-1 replication, we purified and biochemically characterized INI1. We found that INI1 forms multimeric structures. Deletion analysis indicated that the Rpt1 and Rpt2 motifs form the minimal multimerization domain. We isolated mutants of INI1 that are defective for multimerization using a reverse yeast two-hybrid system. Our results revealed that INI1 residues involved in multimerization overlap with IN-binding and nuclear export domains and are required for nuclear retention and co-localization with IN. Multimerization-defective mutants are also defective for mediating the transdominant effect of INI1-S6-(183-294). Furthermore, we found that INI1 is a minor groove DNA-binding protein. Although IN binding and multimerization are required for INI1-mediated inhibition, the acceptor DNA binding property of INI1 may be required for stimulation of in vitro strand transfer activities of IN. Binding of INI1 to IN results in the formation of presumably inactive high molecular weight IN-INI1 complexes, and the multimerization-defective mutant was unable to form these complexes. These results indicate that the multimerization and IN binding properties of INI1 are necessary for its ability to both inhibit integration and influence assembly and particle production, providing insights into the mechanism of INI1-mediated effects in HIV-1 replication.
INI1/hSNF5/BAF47/SMARCB1是一种HIV-1整合酶(IN)结合蛋白,可通过多种方式调节病毒复制。INI1的最小IN结合结构域S6(氨基酸183 - 294)反式抑制晚期事件,而INI1的下调则刺激HIV-1复制的早期事件。根据IN浓度的不同,INI1在体外既能刺激也能抑制整合。为了进一步深入了解其在HIV-1复制中的作用,我们对INI1进行了纯化和生化特性分析。我们发现INI1形成多聚体结构。缺失分析表明,Rpt1和Rpt2基序构成最小的多聚化结构域。我们使用反向酵母双杂交系统分离出了多聚化缺陷的INI1突变体。我们的结果表明,参与多聚化的INI1残基与IN结合域和核输出域重叠,是核滞留以及与IN共定位所必需的。多聚化缺陷突变体在介导INI1 - S6 -(183 - 294)的反式作用方面也存在缺陷。此外,我们发现INI1是一种小沟DNA结合蛋白。虽然INI1介导的抑制作用需要IN结合和多聚化,但INI1的受体DNA结合特性可能是刺激IN体外链转移活性所必需的。INI1与IN的结合导致可能无活性的高分子量IN - INI1复合物的形成,而多聚化缺陷突变体无法形成这些复合物。这些结果表明,INI1的多聚化和IN结合特性对于其抑制整合以及影响组装和病毒颗粒产生的能力是必要的,这为INI1介导的HIV-1复制效应机制提供了见解。